Hims & Hers to offer at-home blood draws and lab testing
Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...
The Super Bowl aired a Hims & Hers commercial that is receiving backlash for its non-FDA approved weight loss drug. This drug ...
During the Super Bowl, Hims & Hers Health aired a commercial called “Sick of the System.” But before the 60-second spot was ...
Yeezy isn’t the only company being called out for its “bait-and-switch” Super Bowl commercial, a Californian company called ...
Hims & Hers makes its Super Bowl commercial debut in 2025 with a spot for the telehealth company's weight loss medications.
Drug industry allies are calling out a Super Bowl ad touting its weight loss medications from telehealth company Hims & Hers, claiming the spot doesn't adequately disclose safety risks of ...
Telehealth provider Hims & Hers Health is defending its planned Super Bowl ad, which is styled as a political manifesto ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Morgan Stanley analyst Craig Hettenbach downgraded Hims & Hers to Equal Weight from Overweight with a price target of $60, up from $42. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback